Brookmont Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.62M Buy
14,249
+3,968
+39% +$925K 1.94% 12
2026
Q1
$2.51M Buy
10,281
+232
+2% +$54K 1.41% 25
2025
Q4
$2.08M Sell
10,049
-66
-0.7% -$13.1K 1.2% 27
2025
Q3
$1.88M Sell
10,115
-439
-4% -$75.2K 1.04% 28
2025
Q2
$1.61M Sell
10,554
-371
-3% -$57K 0.92% 28
2025
Q1
$1.81M Sell
10,925
-632
-5% -$98.9K 1.02% 28
2024
Q4
$1.67M Sell
11,557
-3,034
-21% -$470K 0.89% 28
2024
Q3
$2.36M Sell
14,591
-275
-2% -$43.8K 1.22% 28
2024
Q2
$2.17M Sell
14,866
-181
-1% -$26.9K 1.19% 28
2024
Q1
$2.38M Buy
15,047
+195
+1% +$31K 1.25% 27
2023
Q4
$2.33M Buy
14,852
+64
+0.4% +$9.81K 1.3% 26
2023
Q3
$2.3M Sell
14,788
-85
-0.6% -$14K 1.44% 25
2023
Q2
$2.46M Sell
14,873
-7
-0% -$1.13K 1.48% 24
2023
Q1
$2.31M Buy
14,880
+30
+0.2% +$4.84K 1.45% 26
2022
Q4
$2.62M Sell
14,850
-492
-3% -$85K 1.61% 24
2022
Q3
$2.51M Buy
15,342
+939
+7% +$159K 1.74% 22
2022
Q2
$2.56M Sell
14,403
-494
-3% -$88K 1.76% 20
2022
Q1
$2.64M Buy
14,897
+176
+1% +$29.9K 1.59% 23
2021
Q4
$2.52M Sell
14,721
-610
-4% -$99.9K 1.33% 28
2021
Q3
$2.48M Buy
15,331
+99
+0.6% +$16.9K 1.46% 27
2021
Q2
$2.51M Sell
15,232
-10
-0.1% -$1.66K 1.52% 27
2021
Q1
$2.5M Sell
15,242
-252
-2% -$40.8K 1.61% 23
2020
Q4
$2.44M Sell
15,494
-632
-4% -$93.3K 1.72% 20
2020
Q3
$2.4M Buy
16,126
+287
+2% +$42.5K 1.78% 16
2020
Q2
$2.23M Sell
15,839
-4,055
-20% -$591K 1.78% 17
2020
Q1
$2.61M Sell
19,894
-772
-4% -$110K 2.1% 18
2019
Q4
$3.02M Sell
20,666
-1,757
-8% -$238K 1.8% 25
2019
Q3
$2.9M Sell
22,423
-177
-0.8% -$23.3K 1.66% 25
2019
Q2
$3.15M Buy
22,600
+145
+0.6% +$20.1K 1.89% 23
2019
Q1
$3.14M Buy
22,455
+37
+0.2% +$4.96K 1.93% 24
2018
Q4
$2.89M Buy
22,418
+1,141
+5% +$159K 1.97% 22
2018
Q3
$2.94M Buy
21,277
+129
+0.6% +$17.1K 1.75% 22
2018
Q2
$2.57M Buy
21,148
+268
+1% +$33.4K 1.61% 26
2018
Q1
$2.68M Sell
20,880
-20,776
-50% -$2.81M 1.77% 25
2017
Q4
$5.82M Buy
41,656
+13,320
+47% +$1.86M 2.51% 24
2017
Q3
$3.68M Sell
28,336
-45,266
-62% -$6M 2.02% 24
2017
Q2
$9.74M Sell
73,602
-3,172
-4% -$405K 3.67% 7
2017
Q1
$9.56M Sell
76,774
-54
-0.1% -$6.45K 3.54% 8
2016
Q4
$8.85M Sell
76,828
-6,335
-8% -$732K 3.49% 12
2016
Q3
$9.82M Sell
83,163
-1,663
-2% -$202K 3.66% 7
2016
Q2
$10.3M Sell
84,826
-17,809
-17% -$2.02M 3.75% 2
2016
Q1
$11.1M Sell
102,635
-14,140
-12% -$1.46M 3.56% 6
2015
Q4
$12M Sell
116,775
-14,983
-11% -$1.51M 3.41% 7
2015
Q3
$12.3M Sell
131,758
-7,078
-5% -$685K 3.52% 8
2015
Q2
$13.5M Buy
138,836
+744
+0.5% +$74.5K 3.43% 9
2015
Q1
$13.9M Buy
138,092
+15,217
+12% +$1.55M 3.48% 4
2014
Q4
$12.8M Sell
122,875
-23,428
-16% -$2.47M 3.71% 3
2014
Q3
$15.6M Sell
146,303
-10,309
-7% -$1.07M 3.99% 3
2014
Q2
$16.4M Buy
156,612
+15,884
+11% +$1.61M 3.95% 2
2014
Q1
$13.8M Sell
140,728
-2,407
-2% -$223K 3.8% 2
2013
Q4
$13.1M Buy
143,135
+13,590
+10% +$1.25M 3.62% 10
2013
Q3
$11.2M Buy
129,545
+22,587
+21% +$2.03M 3.66% 2
2013
Q2
$9.18M Buy
+106,958
New +$9.08M 3.8% 2

Other funds holding JNJ

Brookmont Capital Management's JNJ Position: Q2 2026 in Review

Brookmont Capital Management increased its Johnson & Johnson (JNJ) stake by 39% in Q2 2026, buying an estimated $925K and bringing the position to 14,249 shares worth $3.62M. The position accounts for 1.94% of the portfolio, ranked #12.

Brookmont Capital Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.4M in Q2 2014. 2,309 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Brookmont Capital Management held 14,249 shares of Johnson & Johnson worth $3.62M as of Q2 2026.
  • Brookmont Capital Management bought 3,968 Johnson & Johnson shares in Q2 2026, an estimated $925K.
  • Johnson & Johnson made up 1.94% of Brookmont Capital Management's portfolio in Q2 2026, its #12 holding.
  • Brookmont Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Brookmont Capital Management's Johnson & Johnson position peaked at $16.4M in Q2 2014.
  • 2,309 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Brookmont Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.